610 related articles for article (PubMed ID: 31994346)
21. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
22. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
23. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
24. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
26. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study.
Świtlik WZ; Karbownik MS; Suwalski M; Kozak J; Szemraj J
Genet Test Mol Biomarkers; 2019 May; 23(5):353-358. PubMed ID: 30950648
[No Abstract] [Full Text] [Related]
27. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
28. A panel of sputum-based genomic marker for early detection of lung cancer.
Jiang F; Todd NW; Li R; Zhang H; Fang H; Stass SA
Cancer Prev Res (Phila); 2010 Dec; 3(12):1571-8. PubMed ID: 20864512
[TBL] [Abstract][Full Text] [Related]
29. Utilizing MiSeq Sequencing to Detect Circulating microRNAs in Plasma for Improved Lung Cancer Diagnosis.
Geng X; Tsou JH; Stass SA; Jiang F
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373422
[TBL] [Abstract][Full Text] [Related]
30. Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer.
Su J; Leng Q; Lin Y; Ma J; Jiang F; Lee CJ; Fang H; Jiang F
Biomark Cancer; 2018; 10():1179299X18759297. PubMed ID: 29467585
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Serum Paired MicroRNA Ratios for Differential Diagnosis of Non-Small Cell Lung Cancer and Benign Pulmonary Diseases.
Fan L; Sha J; Teng J; Li D; Wang C; Xia Q; Chen H; Su B; Qi H
Mol Diagn Ther; 2018 Aug; 22(4):493-502. PubMed ID: 29922886
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of microRNA expression in operable non-small cell lung cancer patients.
Skrzypski M; Czapiewski P; Goryca K; Jassem E; Wyrwicz L; Pawłowski R; Rzyman W; Biernat W; Jassem J
Br J Cancer; 2014 Feb; 110(4):991-1000. PubMed ID: 24448358
[TBL] [Abstract][Full Text] [Related]
33. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
34. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
35. Expression and clinical significance of miR-139-5p in non-small cell lung cancer.
Yong-Hao Y; Xian-Guo W; Ming X; Jin-Ping Z
J Int Med Res; 2019 Feb; 47(2):867-874. PubMed ID: 30614351
[TBL] [Abstract][Full Text] [Related]
36. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
[TBL] [Abstract][Full Text] [Related]
37. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
38. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
[TBL] [Abstract][Full Text] [Related]
39. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
[TBL] [Abstract][Full Text] [Related]
40. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers.
Xing L; Todd NW; Yu L; Fang H; Jiang F
Mod Pathol; 2010 Aug; 23(8):1157-64. PubMed ID: 20526284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
